Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 16

1.

Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases.

Ogawa M, Kosaka N, Longmire MR, Urano Y, Choyke PL, Kobayashi H.

Mol Pharm. 2009 Mar-Apr;6(2):386-95. doi: 10.1021/mp800115t.

2.

Optical imaging for cervical cancer detection: solutions for a continuing global problem.

Thekkek N, Richards-Kortum R.

Nat Rev Cancer. 2008 Sep;8(9):725-31. doi: 10.1038/nrc2462. Review.

3.

PET scanning and prognosis in Hodgkin's lymphoma.

Brepoels L, Stroobants S.

Curr Opin Oncol. 2008 Sep;20(5):509-16. doi: 10.1097/CCO.0b013e32830b88d3. Review.

PMID:
19106652
4.

Assessing therapeutically developed assays.

Kolesar JM.

Manag Care. 2008 Jul;17(7 Suppl 7):9-12; discussion 17-8. Review.

PMID:
19097282
5.

Optical imaging of the breast.

van de Ven SM, Elias SG, van den Bosch MA, Luijten P, Mali WP.

Cancer Imaging. 2008 Nov 25;8:206-15. doi: 10.1102/1470-7330.2008.0032.

6.

Near infrared fluorescent optical imaging for nodal staging.

Sampath L, Wang W, Sevick-Muraca EM.

J Biomed Opt. 2008 Jul-Aug;13(4):041312. doi: 10.1117/1.2953498. Review.

7.

Toxicity of contrast media: an update.

ten Dam MA, Wetzels JF.

Neth J Med. 2008 Nov;66(10):416-22. Review.

8.

Activatable imaging probes with amplified fluorescent signals.

Lee S, Park K, Kim K, Choi K, Kwon IC.

Chem Commun (Camb). 2008 Sep 28;(36):4250-60. doi: 10.1039/b806854m. Epub 2008 Jul 25. Review.

PMID:
18802536
9.

Near-infrared optical imaging in glioblastoma xenograft with ligand-targeting alpha 3 integrin.

Xiao W, Yao N, Peng L, Liu R, Lam KS.

Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):94-103. doi: 10.1007/s00259-008-0920-0. Epub 2008 Aug 19.

10.

New technologies for human cancer imaging.

Frangioni JV.

J Clin Oncol. 2008 Aug 20;26(24):4012-21. doi: 10.1200/JCO.2007.14.3065. Review.

11.

Biological modulation by lectins and their ligands in tumor progression and metastasis.

Nakahara S, Raz A.

Anticancer Agents Med Chem. 2008 Jan;8(1):22-36. Review.

12.

Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.

Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM.

Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8. Review.

PMID:
18159035
13.

Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin.

Hama Y, Urano Y, Koyama Y, Choyke PL, Kobayashi H.

Biochem Biophys Res Commun. 2006 Sep 29;348(3):807-13. Epub 2006 Aug 4.

PMID:
16904640
14.

In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent.

Hama Y, Urano Y, Koyama Y, Kamiya M, Bernardo M, Paik RS, Krishna MC, Choyke PL, Kobayashi H.

Neoplasia. 2006 Jul;8(7):607-12.

15.

White-light toxicity, resulting from systemically administered 5-aminolevulinic acid, under normal operating conditions.

Aalders MC, vd Vange N, Stewart FA, Klein MG, vd Vijver MJ, Sterenborg HJ.

J Photochem Photobiol B. 1999 Jun;50(2-3):88-93.

PMID:
10515073
16.

Avidin targeting of intraperitoneal tumor xenografts.

Yao Z, Zhang M, Sakahara H, Saga T, Arano Y, Konishi J.

J Natl Cancer Inst. 1998 Jan 7;90(1):25-9.

PMID:
9428779

Supplemental Content

Support Center